NatalizumabDevelopment of anti-drug antibodies and treatment failure: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1897卷 / 1期

关键词：

D O I：

10.1007/s40278-022-11523-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：286 / 286

相关论文

共 50 条

[1] Fingolimod/natalizumabDevelopment of anti-drug antibodies, melanoma and atypical naevi: case report
Reactions Weekly, 2020, 1810 (1) : 103 - 103
[2] AntirheumaticsDevelopment of anti-drug antibodies: 11 case reports
Reactions Weekly, 2018, 1705 (1) : 42 - 42
[3] Adalimumab/infliximabDevelopment of anti-drug antibodies: 7 case reports
Reactions Weekly, 2018, 1701 (1) : 15 - 15
[4] Anti-Drug Antibodies Are Associated with Diminished Drug Levels and Treatment Failure
Kosmac, Miha
Toplak, Natasa
Simonini, Gabriele
Pagnini, Ilaria
Cimaz, Rolando
Serbec, Vladka Curin
Avcin, Tadej
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1099 - S1100
[5] Infliximab/methotrexatePneumonitis and development of anti-drug antibodies: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 241 - 241
[6] InfliximabNew detectable levels of anti-drug antibodies and arthralgia: 3 case reports
Reactions Weekly, 2017, 1680 (1) : 177 - 177
[7] Alglucosidase-alfaLack of efficacy and anti-drug antibodies: 5 case reports
Reactions Weekly, 2021, 1866 (1) : 27 - 27
[8] Adalimumab/certolizumab-pegolDevelopment of anti-drug antibodies: 2 case reports
Reactions Weekly, 2020, 1800 (1) : 16 - 16
[9] InfliximabNew detectable levels of anti-drug antibodies and arthralgia: 3 case reports
Reactions Weekly, 2017, 1647 (1) : 168 - 168
[10] Adalimumab/infliximabAnaphylactic reaction and presence of anti-drug antibodies : 2 case reports
Reactions Weekly, 2021, 1863 (1) : 18 - 18

← 1 2 3 4 5 →